Unit At Mayday

We are delighted to announce that Mayday University Hospital NHS Trust was recently issued an annual performance rating of 3 stars, which places them in the top 28% of Trusts in the UK. This is the highest rating available under the Healthcare Commission rating scheme.The performance rating reports are designed to review the key factors the Trusts need to achieve to deliver a better service to patients. This includes Patient Focus, Clinical Focus, Capacity and Capability Focus, Access to Quality Services, Improving Health and Services Provision. Overall, the Healthcare Commission report concluded that Mayday Hospital is delivering in each of these areas.Dr Jörg Täubel, Managing Director of Richmond Pharmacology, commented: “We have been working closely with the Trust over the past 18 months to facilitate the move of our second unit to Mayday hospital. Throughout this period of time I have been consistently impressed with the quality I experienced when working with the Trust. I am very pleased that this standard has been recognized by the Healthcare Commission. It's reassuring to conduct our trials within such a well managed, acute setting.”Richmond opened the new unit within Mayday University Hospital in May 2005.To view the Healthcare Commission report on Mayday click here.

Latest news

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Von Willebrand Disease Trial – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol

April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read more

Events

Swiss Biotech Day 2025

5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event